grant
DoD Prostate Cancer, Clinical Consortium Award
- Program: FY25 Prostate Cancer Research Program (PCRP) Clinical Consortium Award (CCA)
- Purpose: Speed up the clinical testing of new prostate cancer treatments by coordinating top researchers across multiple institutions.
- What it supports: Building, maintaining, and strengthening the collaboration and infrastructure needed to rapidly run phase 2 and phase 1/2 clinical tr…
Summary: The fiscal year 2025 (FY25) Prostate Cancer Research Program (PCRP) Clinical Consortium Award (CCA) provides support to develop, maintain, and enhance the necessary collaborations and resources to rapidly execute phase 2 and/or phase 2-linked phase 1 (phase1/2) prostate…
Source
Agency: Department of Defense
Sub-agency: Dept. of the Army -- USAMRAA
Awards & funding
Total Funding: $32.5M
Eligibility
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Tags
Cooperative Agreement
Grant
Science and Technology and other Research and Development